High-performance liquid chromatography assay for indorenate in pharmaceutical powders

J. R. Villalobos-Hernandez, R. Arenas-Hernandez, L. Villafuerte-Robles

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A high-performance liquid chromatographic (HPLC) method for quantification of indorenate admixed of pharmaceutical excipients (Pharmatose DCL 21 Povidone USP and Helmcel 200) is described. Indorenate was extracted from the mixtures using a mobile phase composed of acetonitrile and a sodium acetate buffer solution 0.1 M (63:37) and separated from other dissolved components by ion supression-HPLC. The method was standardized using a C-18 column (250 mm × 4.8 mm, i.d., 5 μm). The photometric detector was fixed at 228 or 272 nm depending on the admixed excipients. Validation parameters included linearity, precision, accuracy, reproducibility, and specificity. The method was specific, selective, and capable to distinguish indorenate from their degradation products and the antihypertensive pelanserine.

Original languageEnglish
Pages (from-to)39-45
Number of pages7
JournalDrug Development and Industrial Pharmacy
Volume27
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Dive into the research topics of 'High-performance liquid chromatography assay for indorenate in pharmaceutical powders'. Together they form a unique fingerprint.

Cite this